blinatumomab and auto-HSCT "sandwich " strategy
SZBALL02
Phase 1 other active
Quick answer
blinatumomab and auto-HSCT "sandwich " strategy for B-cell Acute Lymphoblastic Leukemia is a Phase 1 program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- B-cell Acute Lymphoblastic Leukemia
- Phase
- Phase 1
- Modality
- other
- Status
- active